Find resources

Total results with these characteristics: 383

Topic: Vaccine safety and performance

Page 3 of 20
Cost-Effectiveness of a Potential Group B Streptococcal Vaccine Program for Pregnant Women in South Africa

No licensed vaccine for group B Streptococcus (GBS) currently exists, but a polysaccharide-protein conjugate vaccine candidate is currently in trials. This article, published in Vaccine, reports the results of a study that evaluated the potential …

Author: Kim S-Y, Russell LB, Park J, et al.

Publication date: 2014

Cross-Protection Against H7N9 Influenza Strains Using a Live-Attenuated H7N3 Virus Vaccine

This article, published in Vaccine, reports the results of a study examining cross-protection of a H7N3 live attenuated influenza vaccine (LAIV) against avian H7N9 influenza viruses in an animal model. Currently no vaccine targeting the new H7N9 …

Author: Carter DM, Bloom CE, Kirchenbaum GA, et al.

Publication date: 2015

Current Progress in Developing Subunit Vaccines Against Enterotoxigenic Escherichia coli-Associated Diarrhea

This article, published in Clinical and Vaccine Immunology, reports on the development status of subunit vaccines against enterotoxigenic Escherichia coli (ETEC). Currently, there are no available vaccines against ETEC-associated diarrhea. …

Author: Zhang W, Sack DA

Publication date: 2015

Decade of Vaccines

This supplement to Vaccine features articles on the Decade of Vaccines Global Vaccine Action Plan strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles in the supplement cover a range of …

Author: Alonso PL, de Quadros CA, Lal AA, eds.

Publication date: 2013

Decline in Severe Diarrhea Hospitalizations After the Introduction of Rotavirus Vaccination in Ghana: A Prevalence Study

This article, published in BMC Infectious Diseases, reports on the results of a study that examined diarrheal hospitalizations of children aged 59 months and younger before and after the introduction of rotavirus vaccination in Ghana. The results …

Author: Enweronu-Laryea CC, Boamah I, Sifah E, Diamenu SK, Armah G

Publication date: 2014

Development and Preclinical Evaluation of Safety and Immunogenicity of an Oral ETEC Vaccine Containing Inactivated E. coli Bacteria Overexpressing Colonization Factors CFA/I, CS3, CS5 and CS6 Combined With a Hybrid LT/CT B Subunit Antigen, Administered Alone and Together With dmLT Adjuvant

This article, published in Vaccine, describes the development and preclinical testing of new oral vaccine against enterotoxigenic Escherichia coli (ETEC) administered alone and in combination with an adjuvant. The studies found that oral …

Author: Holmgren J, Bourgeois L, Carlin N, et al.

Publication date: 2013

Development of Strategies to Overcome Barriers to Effective Mucosal Immunization of Infants in Developing Countries

This issue of the Old Herborn University Seminar Monograph provides a summary of the discussions at an expert workshop hosted by the Old Herborn University Foundation in June 2010. The discussions were held to examine the mechanisms that may …

Author: Heidt PJ, Walker RI, Rusch V, eds.

Publication date: 2011

Diarrhoea-Related Hospitalizations in Children Before and After Implementation of Monovalent Rotavirus Vaccination in Mexico

This article, published in the Bulletin of the World Health Organization, reports on a study that compared the incidence of diarrhea in young children before and after the national introduction of monovalent rotavirus vaccine in Mexico. The results …

Author: Esparza-Aguilar M, Gastañaduy PA, Sánchez-Uribe E, et al.

Publication date: 2014

A Dose-Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial

This study, published in the Journal of Infectious Diseases, tested the neonatal rotavirus candidate vaccine 116E in a double-blind, placebo-controlled dose-escalation trial in India. Two doses of the Vero cell-adapted vaccine were evaluated in …

Author: Bhandari N, Sharma P, Taneja S, et al.

Publication date: 2009

Early Thimerosal Exposure and Neuropsychological Outcome at 7 and 10 Years

Investigators assessed neurological outcomes by testing more than 1,000 children aged 7 to 10 years and determined that early exposure to mercury from thimerosal-containing vaccines was not associated with deficits in neuropsychological functioning. …

Author: Thompson W, Price C, Goodson B, et al.

Publication date: 2007

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus …

Author: Madhi SA, Cunliffe NA, Steele D, et al.

Publication date: 2010

Effect of Multiple, Simultaneous Vaccines on Polio Seroresponse and Associated Health Outcomes

This article, published in Vaccine, compared vaccination with inactivated polio vaccine (IPV) alone or simultaneously with one other vaccine to vaccination with IPV and four other vaccines among adults in the United States military. The results …

Author: Broderick MP, Oberste MS, Moore D, Romero-Steiner S, Hansen CJ, Faix DJ

Publication date: 2014

Effect of Pentavalent Rotavirus Vaccine Introduction on Hospital Admissions for Diarrhoea and Rotavirus in Children in Rwanda: A Time-Series Analysis

This article, published in The Lancet Global Health, reports on the results of a time-series analysis that examined hospital admissions of children under five years of age due to diarrhea in Rwanda from 2009 to 2014. The authors compared hospital …

Author: Ngabo F, Tate JE, Gatera M, et al.

Publication date: 2016

Effect of Single Dose of SA 14-14-2 Vaccine One Year After Immunisation in Nepalese Children with Japanese Encephalitis: A Case-Control Study

Published in The Lancet, investigators conducted a case-control study and efficacy of the SA 14-14-2 JE vaccine to be 98.5 percent 12 to 15 months after vaccination. ABSTRACT ONLY. (Learn how users in developing countries can gain free access …

Author: Ohrr H, Tandan JB, Sohn YM, et al.

Publication date: 2005

Effect of the Introduction of Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in The Gambia: A Population-Based Surveillance Study

Little information is available about the effect of pneumococcal conjugate vaccines (PCVs) in low-income countries. This article, published in The Lancet Infectious Diseases, presents the results of a study that measured the effects of PCVs on …

Author: Mackenzie GA, Hill PC, Jeffries DJ, et al.

Publication date: 2016

Effectiveness of a Live Oral Human Rotavirus Vaccine After Programmatic Introduction in Bangladesh: A Cluster-Randomized Trial

This article, published in PLoS Medicine, evaluated the efficacy of the two-dose human rotavirus vaccine program on the schedule currently recommended by the World Health Organization in a low-resource population in Bangladesh, the first such …

Author: Zaman K, Sack DA, Neuzil KM, et al.

Publication date: 2017

Effectiveness of a Monovalent Rotavirus Vaccine in Infants in Malawi After Programmatic Roll-Out: An Observational and Case-Control Study

This article, published in The Lancet Infectious Diseases, reports on a study to evaluate the effectiveness of a monovalent rotavirus vaccine in infants in Malawi. The authors found that the vaccine was 64 percent effective in preventing …

Author: Bar-Zeev N, Kapanda L, Tate JE, et al.

Publication date: 2015

Effectiveness of an Indian-made Attenuated Influenza A(H1N1)pdm 2009 Vaccine: A Case Control Study

This article, published in Human Vaccines & Immunotherapeutics, details a case control study to evaluate the effectiveness of a live attenuated A(H1N1)pdm 2009 vaccine produced by the Serum Institute of India, Ltd., which was distributed in …

Author: Kulkarni PS, Agarkhedkar S, Lalwani S, et al.

Publication date: 2014

Effectiveness of Meningococcal Serogroup C Vaccine Programmes

Since the introduction of monovalent meningococcal serogroup C (MenC) glycoconjugate (MCC) vaccines and the implementation of national vaccination programs, the incidence of MenC disease has declined markedly as a result of effective short-term …

Author: Borrow R, Abad R, Trotter C, van der Kils FRM, Vazquez JA

Publication date: 2013

Effectiveness of Monovalent Human Rotavirus Vaccine Against Admission to Hospital for Acute Rotavirus Diarrhoea in South African Children: A Case-Control Study

This study, published in The Lancet Infectious Diseases, examined the effectiveness of rotavirus vaccine in an African setting with a high prevalence of HIV infection. The findings showed that human rotavirus vaccine provided sustained protection …

Author: Groome MJ, Page N, Cortese MM, et al.

Publication date: 2014

Page 3 of 20